Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products Trial N/A Terminated July 29, 2020
A Study to Examine APL-130277 in Patients With Parkinson's Disease Trial Phase 2 Completed July 29, 2020
Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease Trial Phase 3 Completed July 29, 2020
Evaluation of the Uses of a Digital-assisted Self-rehabilitation Device (TELE-PARK) Trial N/A Completed July 26, 2020
Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease Trial N/A Completed July 13, 2020
Circadian & Homeostatic Synchronization Effect on Waking Mobility in Parkinson's Disease Trial N/A Withdrawn July 12, 2020
Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease Trial Phase 1 Unknown July 9, 2020
Validation of a Non-Motor Fluctuation Assessment Instrument (NoMoFA) for Parkinson's Disease Trial N/A Completed July 7, 2020
Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects Trial Phase 1 Terminated July 6, 2020
Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease Trial Phase 3 Completed July 1, 2020
A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease Trial N/A Unknown June 30, 2020
Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine Trial Phase 3 Unknown June 30, 2020
Probiotics-prebiotic Fiber Therapy in Parkinson's Disease Patients With Constipation Trial Phase 3 Completed June 29, 2020